180 related articles for article (PubMed ID: 16133377)
1. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
[TBL] [Abstract][Full Text] [Related]
2. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
[TBL] [Abstract][Full Text] [Related]
3. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
Sacher J; Asenbaum S; Klein N; Geiss-Granadia T; Mossaheb N; Poetzi C; Attarbaschi T; Lanzenberger R; Spindelegger C; Rabas A; Heinze G; Dudczak R; Kasper S; Tauscher J
Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
[TBL] [Abstract][Full Text] [Related]
4. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
[TBL] [Abstract][Full Text] [Related]
5. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
Catafau AM; Pérez V; Penengo MM; Bullich S; Danús M; Puigdemont D; Pascual JC; Corripio I; Llop J; Perich J; Alvarez E
J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
[TBL] [Abstract][Full Text] [Related]
7. Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM.
Herold N; Uebelhack K; Franke L; Amthauer H; Luedemann L; Bruhn H; Felix R; Uebelhack R; Plotkin M
J Neural Transm (Vienna); 2006 May; 113(5):659-70. PubMed ID: 16465456
[TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
Stengler-Wenzke K; Müller U; Barthel H; Angermeyer MC; Sabri O; Hesse S
Neuropsychobiology; 2006; 53(1):40-5. PubMed ID: 16397403
[TBL] [Abstract][Full Text] [Related]
9. In vivo quantification by SPECT of [123I] ADAM bound to serotonin transporters in the brains of rabbits.
Ye XX; Hwang JJ; Hsieh JF; Chen JC; Chou YT; Tu KY; Wey SP; Ting G
Nucl Med Biol; 2004 Nov; 31(8):995-1003. PubMed ID: 15607481
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans.
Frokjaer VG; Pinborg LH; Madsen J; de Nijs R; Svarer C; Wagner A; Knudsen GM
J Nucl Med; 2008 Feb; 49(2):247-54. PubMed ID: 18199621
[TBL] [Abstract][Full Text] [Related]
11. Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
Acton PD; Choi SR; Hou C; Plössl K; Kung HF
J Nucl Med; 2001 Oct; 42(10):1556-62. PubMed ID: 11585873
[TBL] [Abstract][Full Text] [Related]
12. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
[TBL] [Abstract][Full Text] [Related]
13. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
Lin KJ; Liu CY; Wey SP; Hsiao IT; Wu J; Fu YK; Yen TC
Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
[TBL] [Abstract][Full Text] [Related]
14. Imaging the serotonin transporter using (123)I-ADAM in the human brain.
Chou YH; Yang BH; Chung MY; Chen SP; Su TP; Chen CC; Wang SJ
Psychiatry Res; 2009 Apr; 172(1):38-43. PubMed ID: 19239985
[TBL] [Abstract][Full Text] [Related]
15. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
Newberg AB; Plössl K; Mozley PD; Stubbs JB; Wintering N; Udeshi M; Alavi A; Kauppinen T; Kung HF
J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
[TBL] [Abstract][Full Text] [Related]
16. Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults.
Booij J; de Win MM
Nucl Med Biol; 2006 Feb; 33(2):185-91. PubMed ID: 16546672
[TBL] [Abstract][Full Text] [Related]
17. Imaging the availability of serotonin transporter in rat brain with 123I-ADAM and small-animal SPECT.
Hwang LC; Chang CJ; Liu HH; Kao HC; Lee SY; Jan ML; Chen CC
Nucl Med Commun; 2007 Aug; 28(8):615-21. PubMed ID: 17625383
[TBL] [Abstract][Full Text] [Related]
18. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
19. Imaging serotonin transporters using [123I]ADAM SPECT in a parkinsonian primate model.
Ma KH; Huang WS; Huang SY; Cheng CY; Chen CY; Shen LH; Liu JC; Fu YK
Appl Radiat Isot; 2008 Dec; 66(12):1799-803. PubMed ID: 18703341
[TBL] [Abstract][Full Text] [Related]
20. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
